Analysis: Richard W. Allen's sell of ACN (Accenture plc)
Assessment: Low signal
Routine, low-signal trim of a long-held position to fund same-day purchases, with no committee alignment or policy catalyst.
- Member: Richard W. Allen
- Party / state: Republican (state not provided)
- Chamber: House
- Transaction: Sell
- Amount: $15,001 - $50,000
- Ticker: ACN
- Company: Accenture plc
- Trade date: 2026-05-08
- Disclosure date: 2026-06-16
- Disclosure lag: 39 days
Executive summary
The analyzed transaction is a 2026-05-08 sale of Accenture plc (ACN) by Rep. Richard W. Allen, reported in the $15,001–$50,000 range and disclosed on 2026-06-16 (39-day lag). In the user-provided trading history, ACN has been traded 8 times since 2019 (3 buys, 5 sells), and the member also bought AXP and TSM on the same day. Within the EDGAR window provided, Accenture filed 8-Ks on 2026-03-19 (earnings release) and 2026-04-24 (items including entry into a credit agreement), and multiple insiders filed Form 4s in May 2026 reflecting award-type transactions (code 'A').
Within the user-provided history, ACN activity for the member consists of three purchases (2019-08-28, 2019-09-27, 2021-05-13) and five sales (2019-10-17, 2023-03-14, 2025-08-19, 2025-09-12, 2026-05-08). The 2026-05-08 sale is the most recent ACN transaction and is paired with same-day purchases in two other tickers (AXP and TSM), indicating that the ACN sale occurred as part of a multi-trade day in the provided dataset. Other congressional trading activity for ACN in the user-provided cross-member summary shows multiple sales by other members in May 2026, including sales on 2026-05-12, 2026-05-15, and 2026-05-27. Due to lack of live access, this research could not independently retrieve Congress.gov legislative/committee activity, Federal Register items, Regulations.gov dockets, USAspending awards, or contemporaneous news around the trade date, and could not extract Accenture’s 10-K risk/regulatory disclosures.
Timeline
- 2026-03-19 — Accenture plc filed an 8-K reporting Item 2.02 (Results of Operations and Financial Condition) and Item 9.01.
- 2026-04-24 — Accenture plc filed an 8-K reporting Items 1.01, 1.02, 2.03, and 9.01; the filing text preview references entry into a credit agreement.
- 2026-05-05 — Multiple Accenture insiders reported Form 4 transactions coded 'A' (grant/award/other acquisition), with reported prices including 176.995 for some grants.
- 2026-05-08 — Richard W. Allen sold ACN ($15,001 - $50,000).
- 2026-05-08 — Same-day portfolio activity: purchase AXP ($1,001 - $15,000).
- 2026-05-08 — Same-day portfolio activity: purchase TSM ($1,001 - $15,000).
- 2026-05-12 — Other member activity: Julie Johnson sold ACN (amount range not provided in input summary).
- 2026-05-15 — Accenture insiders and directors reported multiple Form 4 transactions coded 'A' (grant/award/other acquisition), typically at $0.
- 2026-05-15 — Other member activity: Ro Khanna sold ACN ($1,001 - $15,000; price in input summary: $168.82).
- 2026-05-19 — Multiple Accenture Form 4 filings were filed on this date (various accession numbers) corresponding to the transactions listed in the user-provided EDGAR enrichment.
- 2026-05-27 — Other member activity: Ro Khanna sold ACN ($15,001 - $50,000; price in input summary: $176.36).
- 2026-06-16 — Richard W. Allen disclosed the 2026-05-08 ACN sale.
Independent analysis of public financial disclosures. Not financial or investment advice.